Evidence map›Paper›PMID 29610859›Full record

ArticleInvestigative ophthalmology & visual science2018

The MT-CO1 V83I Polymorphism is a Risk Factor for Primary Open-Angle Glaucoma in African American Men.

David W Collins, Harini V Gudiseva, Venkata R M Chavali, Benjamin Trachtman, Meera Ramakrishnan, William T Merritt, Maxwell Pistilli, Rebecca A Rossi, Stephanie Blachon, Prithvi S Sankar and 4 more

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Restoring AIBP expression in the retina provides neuroprotection in glaucoma.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Genes · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

David W CollinsScheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Harini V GudisevaScheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Venkata R M ChavaliScheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Benjamin TrachtmanScheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Meera RamakrishnanScheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
William T MerrittScheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Maxwell PistilliScheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Rebecca A RossiScheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Stephanie BlachonHybrigenics Services, Paris, France.
Prithvi S SankarScheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Eydie Miller-EllisScheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Amanda LehmanScheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Victoria AddisScheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Joan M O'BrienScheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
University of Pennsylvania · USPenn Presbyterian Medical Center · USHybrigenics (France) · FR

Funding

Scientific TransparencyP30EY001583 · NEI · UNIVERSITY OF PENNSYLVANIA · PI Qi N Cui · 1985 to 2026
$19.5M
Primary Open Angle African-American Glaucoma Genetics Study RenewalR01EY023557 · NEI · UNIVERSITY OF PENNSYLVANIA · PI O'BRIEN, JOAN M · 2014 to 2025
$18.1M
Bioinformatics Strategies for Genome-Wide Association StudiesR01LM010098 · NLM · UNIVERSITY OF PENNSYLVANIA · PI MOORE, JASON H., WILLIAMS, SCOTT MATTHEW · 2009 to 2023
$5.1M
NEI NIH HHS HHSN263201200001CNEI NIH HHS P30 EY001583NEI NIH HHS R01 EY023557NIH HHS HHSN263201200001ENLM NIH HHS R01 LM010098
6 · The paper itself

Abstract

Purpose: We investigate the function of the V83I polymorphism (m.6150G>A, rs879053914) in the mitochondrial cytochrome c oxidase subunit 1 (MT-CO1) gene and its role in African American (AA) primary open-angle glaucoma (POAG). Methods: This study used Sanger sequencing (1339 cases, 850 controls), phenotypic characterization of Primary Open-Angle African American Glaucoma Genetics study (POAAGG) cases, a masked chart review of CO1 missense cases (V83I plus M117T, n = 29) versus wild type cases (n = 29), a yeast 2-hybrid (Y2H) cDNA library screen, and quantification of protein-protein interactions by Y2H and ELISA. Results: The association of V83I with POAG in AA was highly significant for men (odds ratio [OR] 6.5; 95% confidence interval [CI] 2.0-21.3, P = 0.0001), but not for women (OR 1.1; 95% CI, 0.62-2.00, P = 0.78). POAG cases having CO1 double missense mutation (V83I + M117T, L1c2 haplogroup) had a higher cup-to-disc ratio (0.77 vs. 0.71, P = 0.04) and significantly worse visual function (average pattern standard deviation, 6.5 vs. 4.3, P = 0.009; average mean deviation -10.4 vs. -4.5, P = 0.006) when compared to matched wild type cases (L1b haplogroup). Interaction of the V83I region of CO1 with amyloid beta peptide (Aβ) was confirmed by ELISA assay, and this interaction was abrogated by V83I. A Y2H screen of an adult human brain cDNA library with the V83 region of CO1 as bait retrieved the UBQLN1 gene. Conclusions: The V83I polymorphism was associated strongly with POAG in AA men and disrupts Aβ-binding to CO1. This region also interacts with a neuroprotective protein, UBQLN1.

Indexed as

Mutation, MissensePolymorphism, Single NucleotideAdaptor Proteins, Signal TransducingAgedAmyloid beta-PeptidesAutophagy-Related ProteinsBlack or African AmericanCarrier ProteinsCase-Control StudiesCell Cycle ProteinsDNA Mutational AnalysisElectron Transport Complex IVEnzyme-Linked Immunosorbent AssayFemaleGlaucoma, Open-AngleHumansAdaptor Proteins, Signal TransducingAmyloid beta-PeptidesAutophagy-Related ProteinsCarrier ProteinsCell Cycle Proteinscytochrome c oxidase subunit I, humanElectron Transport Complex IVUBQLN1 protein, human

Identifiers

PMID29610859
PMCPMC5886029
OpenAlexW2795853717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.